+51.6%
CME vs FCUV
-99.2%
+150.8%
-31.1%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | FCUV | Excess | Alpha |
|---|---|---|---|---|
| 1D | -0.8% | -7.0% | +6.2% | -0.8% |
| 7D | -0.6% | -63.8% | +63.1% | -0.6% |
| 30D | +4.7% | -14.7% | +19.4% | +4.7% |
| 3M | +7.8% | +65.3% | -57.5% | +7.9% |
| 6M | -11.0% | -68.5% | +57.5% | -11.0% |
| YTD | +4.0% | -83.0% | +87.1% | +3.9% |
| 1Y | +9.1% | -94.4% | +103.5% | +8.6% |
| All | +51.6% | -99.2% | +150.8% | +50.6% |
Cumulative growth
Daily Returns
Daily percentage return beside FCUV.
Daily Out/Under-Performance
Portfolio return minus FCUV return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × FCUV return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded FCUV wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling